Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Name: Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
Published: 2017
License: Public Domain

Ciusss de L'Est de l'Île de Montréal · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

hematologic cancer, relapse leukemia, relapsed adult all, relapsed adult aml, relapsed cll, relapsed non hodgkin lymphoma, relapsed hodgkin's lymphoma, relapsed myelodysplastic syndromes, relapsed multiple myeloma, allogeneic hematopoietic stem cell transplantation, relapsed hematopoietic malignancy, hla matched donor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 806979
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.